A Dyadic Intervention for Young Adult Patients With Cancer and Their Partner Caregivers
Part of paid clinical trials in Boston, Massachusetts.
- Sponsor
- Massachusetts General Hospital
- Study ID
- NCT06172907
- Status
- Recruiting
Conditions
- Cancer
- Caregiver Burden
- Coping Skills
- Couples
- Psychological Distress
- Survivorship
Eligibility Criteria
- Sex
- ALL
- Age
- 25 Years - 39 Years
- Healthy Volunteers
- Not accepted
Interventions
- Young Adults Coping with Cancer Together Intervention — BEHAVIORALThis intervention is based on cognitive-behavioral therapy and couples' therapy. It aims to improve cancer and caregiving-related self-efficacy and coping, as well as promote relationship maintenance in context of cancer. The intervention will be delivered by a trained mental health practitioner and include didactics, experiential exercises, and home practice.
Study Details
The purpose of this pilot study is to examine the feasibility and acceptability of a brief psychotherapy intervention to improve psychosocial coping and maintain couple relationships among young adults (aged 25-39) with cancer and their caregiving partners.
Key Dates
- Start date
- Apr 19, 2024
- Status verified
- Dec 2025
- Primary completion
- Jun 30, 2026
- Completion
- Dec 31, 2026
Study Design
- Enrollment
- 20 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- SUPPORTIVE_CARE
Arms
- Other: Young Adults Coping with Cancer Together InterventionYoung adults with cancer and their partner-caregivers will attend dyadic virtual psychotherapy sessions lasting 45-60 minutes on a weekly basis for eight weeks.
Primary Outcome Measure
Feasibility of Intervention [ Time Frame: 14 +/- 2 Weeks ]
Central Contacts
- Jamie M Jacobs, Ph.D.617-643-1777
- Zeba N Ahmad, Ph.D.617-724-1586
Locations (4)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Massachusetts General Hospital Cancer Center | Boston | Massachusetts | 02114 | Jamie M Jacobs, PhD Jamie M Jacobs, PhD (PRINCIPAL_INVESTIGATOR) |
| Emerson Hospital/MGH Cancer Center | Concord | Massachusetts | 01742 | Jamie M Jacobs, PhD Jamie M Jacobs, PhD (PRINCIPAL_INVESTIGATOR) |
| Mass General at North Shore Cancer Center | Danvers | Massachusetts | 01923 | Jamie M Jacobs, PhD Jamie M Jacobs, PhD (PRINCIPAL_INVESTIGATOR) |
| Mass General at Newton Wellesley Hospital | Newton | Massachusetts | 02462 | Jamie M Jacobs, PhD Jamie M Jacobs, PhD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Boston, MA
Related Studies
- Evaluation of Non-Invasive Assays for the Detection of Urothelial CancerRecruiting · Lahey Clinic · Burlington, Massachusetts
- Childhood Cancer Survivor StudyRecruiting · St. Jude Children's Research Hospital · Birmingham, Alabama
- Study of the CDK4/6 Inhibitor Abemaciclib in Solid Tumors Harboring Genetic Alterations in Genes Encoding D-Type Cyclins or Amplification of CDK4 or CDK6PHASE2 · Recruiting · Dana-Farber Cancer Institute · Boston, Massachusetts
- SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and RegistryRecruiting · Massive Bio, Inc. · Birmingham, Alabama